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Staphylococcus aureus biofilm plays a major role in implant-associated infections.
Here, the susceptibility of biofilm S. aureus to daptomycin, fosfomycin, vancomycin,
trimethoprim/sulfamethoxazole, linezolid, and rifampicin was investigated by isothermal
microcalorimetry (IMC). Moreover, the persister status of cells isolated from S. aureus
biofilm after treatment with vancomycin was also analyzed. S. aureus biofilm was
tolerant to all the antibiotics tested [minimum biofilm bactericidal concentration
(MBBC) > 256 µg/ml], except to daptomycin [MBBC and minimum biofilm eradicating
concentration (MBEC) = 32 µg/ml] and rifampin (MBBC and MBEC = 128 µg/ml).
After the treatment of MRSA biofilm with 1024 µg/ml vancomycin, ∼5% cells survived,
although metabolically inactive (persisters). Interestingly, IMC revealed that persister
bacteria reverted to a normal-growing phenotype when inoculated into fresh medium
without antibiotics. A staggered treatment of MRSA biofilm with vancomycin to kill
all the metabolically active cells and daptomycin to kill persister cells eradicated the
whole bacterial population. These results support the use in the clinical practice
of a therapeutic regimen based on the use of two antibiotics to kill persister cells
and eradicate MRSA biofilms. IMC represents a suitable technique to characterize in
real-time the reversion from persister to metabolically-active cells.
Keywords: Staphylococcus aureus, biofilm, persister cells, antibiotic activity, isothermal microcalorimetry,
vancomycin, biofilm-associated infection
INTRODUCTION
Staphylococcus aureus is a pathogenic organism responsible for a wide variety of bacterial infections
affecting different anatomic districts, including bloodstream, respiratory tract, skin, soft tissues,
and bone (Kuroda et al., 2001; DeLeo and Chambers, 2009; Tong et al., 2015). S. aureus also
colonizes necrotic tissues and abiotic surfaces, thus forming biofilms (Arciola et al., 2015). Within
a biofilm, bacteria, embedded in an extracellular matrix, develop into a complex community
presenting functional and structural heterogeneity (Zimmerli et al., 2004). In vivo, the biofilm
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extracellular matrix might protect the embedded bacterial cells
from the attack of some antimicrobials and host immunity
(Bjarnsholt et al., 2013).
Biofilms are also characterized by cells with a slow- and
non-growing phenotype, which are able to survive in the presence
of high concentrations of bactericidal antibiotics (Lewis, 2005),
thus contributing to infection relapses. These so-called ‘persister
cells’ represent a small percentage of a microbial population,
which are genetically susceptible but phenotypically resistant
to antimicrobials thanks to their non-growing quiescent state
(Fisher et al., 2017; Grassi et al., 2017). Persistence is, therefore,
markedly distinct from resistance, which is an inherited ability
acquired by the total microbial population and it implies the
capacity of bacteria to grow and replicate in the presence of
high concentrations of antimicrobial with no dependency on the
treatment duration (Scholar and Pratt, 2000; Brauner et al., 2016).
Even though persister cells may be stochastically induced
(Maisonneuve et al., 2013), their emergence can also be fostered
as a stress response to particular environmental conditions,
such as high concentrations of antibiotics (Krut et al., 2004)
and nutritional restrictions (Nguyen et al., 2011). Additionally,
the amount of cells that spontaneously enters this dormant
state depends on the growth stage of a culture (Wood et al.,
2013). Indeed, levels of persisters frequently increase during the
stationary growth phase and in biofilms, most likely functioning
as bacterial survival strategy. In fact, when the antibiotic
treatment kills normal-growing cells, persisters survive and
resuscitate upon treatment interruption, thus repopulating the
biofilm (Lewis, 2007).
The physical shielding offered by the extracellular matrix,
the bacterial resistance (Brauner et al., 2016) and the ability of
persister cells to survive lethal treatments represent some of the
main causes of infection recalcitrance and therapeutic failure
(Lewis, 2008; Conlon et al., 2016).
The increasing use in medicine of indwelling devices, such as
orthopedic joint prosthesis, cardiac valves, breast implants and
also catheters, fosters the development of infections difficult to
treat due to bacteria (including S. aureus) forming biofilm on the
material surface. Current available therapeutic options include
drugs with bactericidal and bacteriostatic activities, both as
monotherapy and in combination regimens, such as vancomycin,
daptomycin, linezolid, trimethoprim/sulfamethoxazole,
rifampicin, and fosfomycin. Vancomycin remains one of
the pharmacological choices for the prophylaxis or treatment
of invasive staphylococcal infections (Liu et al., 2011) and it
is the antibiotic of first choice after other treatments failed
(Boneca and Chiosis, 2003). This glycopeptide exerts a slow
bactericidal activity against gram positive bacteria inhibiting
the cell wall biosynthesis by strongly binding to the terminal
D-Ala-D-Ala dipeptide on the nascent peptidoglycan chains
(Katzung et al., 2012).
The aims of this study are: (i) to investigate the in vitro
anti-biofilm activity of selected antibiotics commonly
used in the clinical practice for the management of
implant-associated infections due to methicillin- resistant
and methicillin-susceptible S. aureus by conventional tests
and isothermal microcalorimetry (IMC); (ii) to evaluate
the presence of persister cells in biofilm grown in vitro
after the exposure to high bactericidal concentrations of
vancomycin; (iii) to characterize the persisters metabolic




Methicillin-resistant S. aureus (MRSA) ATCC 43300 and
methicillin-susceptible S. aureus (MSSA) ATCC 29213 were used
in this study. Bacteria were stored in cryovial bead preservation
systems (Microbank; PRO-LAB DIAGNOSTICS, Richmond Hill,
ON, Canada) at −80◦C. All bacterial strains were cultured on
Tryptic Soy Agar (TSA) (VWR Chemicals, Leuven, Belgium)
for 24 h at 37◦C in an ambient air incubator. Inocula were
prepared according to a McFarland standard turbidity of 0.5
(λ = 565 ± 15 nm) and determined by colony forming units
(CFUs) counting.
Antimicrobial Agents
Fosfomycin (InfectoPharm, Heppenheim, Germany), rifampicin
(Sandoz Pharmaceuticals, Steinhausen, Switzerland) and
vancomycin (Hexal, Holzkirchen, Germany) were obtained
as powder and reconstituted using sterile pyrogen-free water.
Daptomycin (Novartis Pharma Schweiz, Basel, Switzerland)
was obtained as a powder and dissolved in sterile pyrogen-free
0.9% saline. Trimethoprim/sulfamethoxazole (ratio 1:5) (Roche
Pharma, Reinach, Schweiz) and linezolid (Pfizer Pharma, Berlin,
Germany) were supplied in liquid form.
Evaluation of the Minimum Inhibitory
Concentration (MIC) by Broth
Macrodilution and Etest
The MICs of different antibiotics against planktonic S. aureus
cells were evaluated using either broth macrodilution according
to the CLSI guidelines (CLSI, 2012) or Etest (bioMérieux SA,
Lyon, France). Briefly, a standard inoculum of 1–5 105 CFUs/ml
was prepared in Cation Adjusted Müller Hinton broth (CAMHB)
(Becton, Dickinson and Company, Le Pont-de-Claix, France)
and serial twofold dilutions of each antibiotic were added to the
test tubes. Next, macrodilution tubes were incubated at 37◦C
for 18 h. The MIC was defined as the lowest concentration
of antimicrobial that completely inhibited the growth of the
organism in the tubes, as detected by unaided eye. Etest was
performed on Müller Hinton Agar (MHA) according to the
manufacturer’s instructions. After incubation at 37◦C for 18 h,
the MIC was determined as the concentration value where the
inhibition ellipse intersected the scale of the strip.
Isothermal Microcalorimetry (IMC) Assay
Isothermal microcalorimetric analysis was performed as
previously described (Butini et al., 2018b). Briefly, an isothermal
microcalorimeter (TAM III; TA Instruments, New Castle, DE,
United States) equipped with 48 calorimeter channels and a
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detection limit of 0.2 µW was used. Glass ampoules were sealed
for air tightness and introduced into the microcalorimeter, first
in the equilibration position and, after 15 min, in the measuring
position. Heat flow (µW) and total heat (J) were monitored
in real-time for 24 and 48 h when testing antibiotics against
planktonic and biofilm bacteria, respectively.
Evaluation of the Antibiotic Activity
Against Planktonic Bacteria by IMC
For the microcalorimetric investigation of antibiotic activity
against planktonic MRSA and MSSA, glass ampoules were
inoculated with 1–5 × 105 CFUs/ml cells and twofold serial
dilutions of antibiotic in CAMHB. When daptomycin and
fosfomycin, were tested, CAMHB was supplemented with
50 mg/l Ca2+ and 25 mg/l glucose-6-phosphate, respectively.
Ampoules containing inoculated CAMHB without any
antibiotics were included as growth control and ampoules
with sterile CAMHB as negative control. The minimum
heat inhibitory concentration (MHIC) for planktonic was
defined as the lowest antimicrobial concentration that inhibited
growth-related heat production during 24 h-incubation in the
microcalorimeter, as previously reported (Oliva et al., 2014;
Gonzalez Moreno et al., 2017; Butini et al., 2018b). For each
antibiotic two independent experiments were performed, if
the two MHIC values were discordant, a third experiment
was carried out.
Evaluation of the Anti-Biofilm Activity by
IMC and Sonication/Colony Counting
Porous glass beads (VitraPor; ROBU, Hatter, Germany).
Diameter, 4 mm; pore size, 60 µm; porosity, 0.2 m2/g) were
statically incubated in Trypticase Soya broth (TSB) inoculated
with 2–3 bacterial colonies (corresponding to ∼1 × 107
CFUs/ml) for 24 h at 37◦C. The ratio between glass beads
and bacterial suspension (ml) was 1:1. After incubation,
beads were washed three times with 0.9% sterile saline and
exposed to twofold serial dilutions of antibiotic in CAMHB
for 24 h. A positive control consisting in biofilm incubated
without treatment was included, as well as a sterile bead
as a negative control. Next, beads were rinsed (3x) and
placed in glass ampoules containing 3 ml of fresh CAMHB.
The minimum biofilm bactericidal concentration (MBBC)
was defined as the lowest antimicrobial concentration that
strongly reduced the number of viable bacterial cells within
the biofilm, therefore leading to undetectable heat values
(no biofilm cell metabolic activity) during 48 h-incubation
in fresh medium (Butini et al., 2018b). For each antibiotic
two independent experiments were performed, if the
two MBBC values were discordant, a third experiment
was carried out.
The biofilm beads treated with MBBC of each antibiotic
were collected and further analyzed by sonication and colony
counting. Briefly, after calorimetric analysis, beads were washed
and transferred to a 2 ml Eppendorf tubes containing 1 ml PBS
(pH 7.4, 10 mM), vortexed for 30 s, sonicated at 40 kHz for
1 min in a bath sonication instrument at 40 kHz and 0.2 W/cm2
(BactoSonic, Bandelin, Berlin, Germany) and finally vortexed
for 30 s, as previously described (Trampuz et al., 2007). The
sonication fluid was serially diluted and aliquots thereof were
plated on TSA (plate diameter 92 mm) and incubated at 37 ◦C
for 24 h. Bacterial colonies were expressed as CFUs/ml (plating
detection limit = 20 CFUs/ml). The minimum biofilm eradicating
concentration (MBEC) was then defined as the lowest antibiotic
concentration required to kill all sessile cells (0 CFUs/bead on
plate counts) (Butini et al., 2018b).
The pharmacodynamic parameters (MBBC and MBEC) used
to quantify the anti-biofilm activity of antibiotics measured
by IMC were defined according to the suggestions reported
by Macia et al. (2014).
Isolation and Characterization of
Persister Cells From Biofilms After
Treatment With High Concentrations of
Vancomycin
To isolate persister cells of MRSA, a biofilm, formed as
previously described, was exposed to 1024 µg/ml vancomycin.
Beads with untreated biofilm were included as growth control,
as well as sterile beads as negative control. Next, beads
were washed and sonicated as described above to dislodge
cells survived to the antibiotic treatment. Bacteria were
diluted to a final concentration of ∼1 × 105 CFUs/ml in
PBS/1%CAMHB (in order to avoid the re-activation of
the metabolism in case of persister cells), as previously
described (Grassi et al., 2017), and incubated at 37◦C
with and without 100x MIC of vancomycin. MRSA cells
dislodged from an untreated biofilm were inoculated (final
concentration ∼1 × 105 CFUs/ml) either in PBS/1%CAMHB
or in CAMHB and used as cell viability controls. After
1, 3 and 6 h-incubation, samples were serially diluted
and plated on TSA for CFUs counting (plating detection
limit = 50 CFUs/ml).
The time needed for persisters to revert into normal-growing
cells was monitored by real-time investigation of heat production
by IMC. Briefly, bacterial biofilm was formed and treated for
24 h as reported above. After sonication of beads, bacteria were
diluted to ∼1 × 105 CFUs/ml and incubated in glass ampoules
filled with fresh CAMHB. Untreated biofilm was sonicated as
well and diluted free-floating bacteria were incubated in CAMHB
and used as control. Heat flow (µW) and total heat (J) were
monitored for 15 h at 37◦C.
Antimicrobial Activity of Daptomycin
Versus Persister Cells Survived After
Vancomycin Treatment
To evaluate a potential synergistic eradicating activity of
the sequential use of vancomycin and daptomycin against
staphylococcal biofilm, a 24 h-old MRSA biofilm was formed
on porous glass beads, as previously reported. After incubation,
beads were rinsed (3x) and exposed to high vancomycin
concentrations (1024 µg/ml) for 24 h and, after this time,
beads were carefully rinsed and further exposed to sub-
eradicating concentrations of daptomycin (16 µg/ml). After
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treatment suspension and sonication, serial dilutions of the
sonication fluids were plated on TSA plates (plating detection
limit = 50 CFUs/ml) and colonies were counted after 24 h
incubation at 37◦C.
Data Analysis
Isothermal microcalorimetry data analysis was accomplished
using the manufacturert’s software (TAM Assistant; TA
Instruments, New Castle, DE, United States). The resulting
data were expressed as heat flow (µW) versus time (h),
as measure of the instantaneous heat produced at any
time point, and as heat (J) versus time (h), as cumulative
amount of heat produced during the experiment. Figures
were plotted using GraphPad Prism 6.00 (GraphPad
Software, La Jolla, CA, United States). From IMC data,
the microbiologically relevant information growth rate
(µ, J/h) and lag phase (λ, h) were derived according to
growth models, as previously reported (Yang et al., 2007;
Howell et al., 2011; Braissant et al., 2013).
RESULTS
Antimicrobial Susceptibility Testing
Several antibiotics were tested against MRSA and MSSA.
The respective MICs are reported in Table 1. Planktonic
cells of both strains were susceptible to the assayed
drugs by broth macrodilution, according to the EUCAST
breakpoint recommendations (EUCAST, 2017). Rifampicin
exhibited the lowest MIC = 0.008 µg/ml, followed by
trimethoprim/sulfamethoxazole and daptomycin (MIC = 0.12
and 0.25 µg/ml, respectively). Vancomycin MIC (1 µg/ml)
resulted slightly lower than that observed for fosfomycin and
linezolid (both 2 µg/ml).
No differences in MRSA and MSSA susceptibility profiles
were observed, except when bacteria were challenged with
trimethoprim/sulfamethoxazole and rifampicin. The former
showed a twofold lower MIC against MSSA, while the latter
a twofold higher MIC (0.12 and 0.016 µg/ml, respectively).
These data were confirmed by Etest, which showed similar
results for the antibiotics assayed within a twofold dilution
range (Table 1).
Evaluation of the Antibiotic Activity
Against Planktonic Bacteria by IMC
Supporting Information Figures 1, 2 depict the heat flow
(µW) curves generated by the metabolic activity of planktonic
MRSA (Supplementary Figure S1) and MSSA (Supplementary
Figure S2), when incubated with different concentrations of
antimicrobials. The heat produced by the tested strains is
reported instantaneously at any time point. The mathematical
integration of this set of values is referred to as total heat (J),
which represents the heat developed by the bacterial metabolic
activity during the complete duration of the experimental
observation (Supplementary Figure S1, S2). MHIC values
determined by IMC ranged between 0.008 and 4 µg/ml (when
testing rifampicin and linezolid, respectively), exhibiting a good
correlation with data obtained using standard susceptibility
testing (Table 1).
Evaluation of the Anti-Biofilm Activity by
IMC and Sonication/Colony Counting
The activity of all antibiotics was also evaluated against MRSA
and MSSA biofilms formed on porous glass beads and the
viability of cells remaining on the bead was analyzed by IMC.
Figures 1, 2 shows the microcalorimetric curves generated by
the heat flow related to the metabolic activity of biofilm cells
still viable after the antibiofilm treatment (the corresponding
total heat graphs are reported in Supplementary Figures S3, S4,
respectively). The most effective biofilm bactericidal activity
was exerted by daptomycin (MBBC: 32 µg/ml) and rifampicin
(MBBC: 128–256 µg/ml) against both MRSA and MSSA
strains. Conversely, a strong bactericidal effect was not
detected when the staphylococcal biofilms were challenged with
concentrations of fosfomycin, vancomycin, and linezolid up to
1024 µg/ml.
These observations are in agreement with the results obtained
after sonication and colony counting (Figure 3). The number
of cells from untreated biofilms used as positive control
were 8.56 ± 3.59 × 106 CFUs/ml and 8.13 ± 3.65 × 106
CFUs for MRSA and MSSA, respectively. No colonies were
detected after treating 24 h-old biofilms of both strains
with either daptomycin or rifampicin, thus MBBCs for these
antibiotics corresponded to the MBEC. When compared to
TABLE 1 | The MICbroth, MICEtest, MHIC and MBBC (µg/ml) of tested antibiotics against planktonic and biofilm MRSA and MSSA.
MRSA MSSA
Antibiotic MICbroth MICEtest MHIC MBBC MICbroth MICEtest MHIC MBBC
DAP 0.25 0.25 0.25 32 0.25 0.5 0.25 32
FOS 2 1 2 >1024 2 0.75 2 >1024
VAN 1 1 2 >1024 1 1 1 >1024
TMP/SXT 0.25 n.t. 0.5 >256 0.12 n.t. 0.5 >256
LZD 2 n.t. 2 >1024 2 n.t. 4 >1024
RIF 0.008 0.006 0.016 128 0.016 0.012 0.008 256
Daptomycin (DAP), fosfomycin (FOS), vancomycin (VAN), trimethoprim/sulfamethoxazole (TMP/SXT), linezolid (LNZ), and rifampicin (RIF). TMP/SXT concentrations are
expressed as trimethoprim concentrations. n.t., not tested.
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FIGURE 1 | Isothermal microcalorimetry evaluation of antimicrobial activity of daptomycin, fosfomycin, vancomycin, trimethoprim/sulfamethoxazole, linezolid, and
rifampicin against biofilm MRSA. Numbers represent antibiotic concentrations (µg/ml). A negative control has been used to confirm medium sterility (NC).
Trimethoprim/sulfamethoxazole concentrations are expressed as the trimethoprim concentrations. Circled values represent the MBBC. Representative data of
replicated experiments are reported.
the untreated biofilm, the highest tested concentrations of
fosfomycin, vancomycin, and trimethoprim/sulfamethoxazole
against biofilm MRSA determined a CFU number reduction of at
least 1 log10, whereas linezolid reduced the staphylococcal biofilm
more than 2 log10 CFU s/ml.
Conversely, for MSSA, a biofilm reduction exceeding
1 log10 was achieved when treating the biofilm with
trimethoprim/sulfamethoxazole and linezolid. The treatment
with fosfomycin and vancomycin resulted in a lower anti-biofilm
activity, with a biofilm reduction remaining lower than 1 log10.
The timely anti-biofilm activity of daptomycin and rifampicin
was further suggested by the mathematical analysis of IMC
curves. Indeed, as shown for MRSA in Figure 4, a sharp
decrease in the growth rate (µ (J/h)) was observed when
biofilm was treated with increasing concentrations of these two
antibiotics, up to the MBBCs, as compared to the untreated
control. A reduction from ∼0.47 to ∼0.27 J/h was calculated
already after treatment with 16 µg/ml daptomycin and a 1µ
∼ −0.17 J/h (from ∼0.33 to ∼0.16 J/h) was observed when
biofilm was challenged with 64 µg/ml rifampicin. Treatment
with trimethoprim/sulfamethoxazole also induced a decrease
in the metabolic functions of the challenged biofilm until a
concentration of 128 µg/ml (1µ ∼ −0.18 J/h, calculated from
µ of untreated and treated sample (128 µg/ml)). A doubled
concentration (256 µg/ml) did not further affect the biofilm cells
growth (1µ∼ 0.04 J/h). Linezolid and fosfomycin did not cause a
similarly remarkable growth reduction after 24 h-treatment with
increasing concentrations (1µ∼−0.05 J/h from 32 to 512 µg/ml
and 1µ ∼ −0.003 J/h from 256 to 512 µg/ml, respectively).
Similarly, vancomycin highest tested concentrations (from 512 to
1024 µg/ml) did not deeply affect the bacterial metabolic growth
pattern (1µ∼−0.05). A comparable anti-biofilm behavior could
be appreciated when analyzing the lag phase [λ (h)] between the
experiment start and the onset of the exponential growth. Indeed,
the number of biofilm viable cells drastically decreased after being
challenged with increasing, yet lower absolute concentrations of
daptomycin and rifampicin, thus leading to a noticeable delay
in the heat flow production (1λ ∼ 15.38 h from 0 to 16 µg/ml
and 1λ ∼ 17.89 h from 0 to 64 µg/ml, respectively). A gradual
increase in λ was observed after trimethoprim/sulfamethoxazole
treatment (1λ∼ 5.35 h from 8 to 256 µg/ml) and, in accordance
with the growth rate data, fosfomycin (1λ ∼ 1.01 h from 256 to
1024 µg/ml) and linezolid (1λ ∼1.77 h from 32 to 512 µg/ml
and 1λ ∼3.79 h from 512 to 1024 µg/ml) did not give a strong
delay in the start of exponential growth phase using gradually
increasing concentrations. High concentrations of vancomycin
(512 and 1024 µg/ml) demonstrated to induce a similar time
delay (1λ ∼2.71 h), in accordance with the effect exerted on the
growth rate. Similar results were also obtained from the analysis
of the heat flow curves produced by MSSA biofilm after the
treatment with the same antibiotics (Supplementary Figure S5).
Based on the analysis of the total heat production related to the
biofilm recovery after 48 h-incubation in the microcalorimeter
(Table 2), a minimum reduction of heat developed by biofilm
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FIGURE 2 | Isothermal microcalorimetry evaluation of antimicrobial activity of daptomycin, fosfomycin, vancomycin, trimethoprim/sulfamethoxazole, linezolid, and
rifampicin against biofilm MSSA. Numbers represent antibiotic concentrations (µg/ml). A negative control has been used to confirm medium sterility (NC).
Trimethoprim/sulfamethoxazole concentrations are expressed as the trimethoprim concentrations. Circled values represent the MBBC. Representative data of
replicated experiments are reported.
FIGURE 3 | Evaluation of the anti-biofilm activity of the highest tested concentrations (µg/ml) of daptomycin (DAP), fosfomycin (FOS), vancomycin (VAN),
trimethoprim/sulfamethoxazole (TMP/SXT), linezolid (LZD) and rifampicin (RIF) against biofilm of either MRSA or MSSA by sonication and colony counting (Log10
CFUs/mL). GC 48h; growth control of untreated 48 h-old biofilm. Data are expressed as mean ± SD, n = 3.
samples of around 25% was estimated after treatment with
concentrations ranging from 16 to 1024 µg/ml of the different
tested antibiotics, as compared to the growth control. The
only exception was recorded after MSSA antibiofilm treatment
with trimethoprim/sulfamethoxazole and linezolid, which
induced a total heat reduction not exceeding the threshold
of 25%. To increase the reduction rate over 50% during
48 h-incubation, a minimum of twofold concentrated antibiotic
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FIGURE 4 | Analysis of growth rate (µ, J/h) and lag phase (λ, h) obtained from
IMC data of MRSA biofilm treatment with daptomycin (DAP), fosfomycin
(FOS), vancomycin (VAN), trimethoprim/sulfamethoxazole (TMP/SXT), linezolid
(LNZ) and rifampicin (RIF). The bacterial growth rate (µ, J/h) and the lag phase
(λ, h) are plotted against antibiotic concentrations (µg/ml). TMP/SXT
concentrations are expressed as trimethoprim concentrations.
dilutions were generally needed (≥32 µg/ml). Nevertheless,
trimethoprim/sulfamethoxazole did not halve the metabolic
activity of the treated samples in comparison to the untreated
biofilm even at concentrations higher than 128 µg/ml. The
same trend of increasing antibiotic concentrations was
not observed when analyzing heat reductions exceeding
75%. Indeed, bactericidal compounds like daptomycin and
rifampicin gave a heat reduction ≥ 75% with the same
concentrations (MBBCs = 32, 128, and 256 µg/ml) that
also decreased the total heat value over 48 h-analysis,
whereas the other drugs did not succeed in strongly
reducing the total amount of heat associated to the biofilm
recovery after treatment.
TABLE 2 | Percentage of reduction in heat (J) produced by MRSA and MSSA
biofilms treated with the different tested antibiotics.
MRSA MSSA
Antibiotic ≥25% ≥50% ≥75% ≥25% ≥50% ≥75%
DAP 16 32 32 32 32 32
FOS 256 – – 1024 1024 –
VAN 256 1024 – 1024 – –
TMP/SXT 128 – – – – –
LZD 32 1024 – – – –
RIF 32 128 128 128 256 256
Daptomycin (DAP), fosfomycin (FOS), vancomycin (VAN),
trimethoprim/sulfamethoxazole (TMP/SXT), linezolid (LNZ), and rifampicin
(RIF). Numbers in bold represent the MBBCs and concentrations are expressed in
µg/ml. TMP/SXT concentrations are expressed as trimethoprim concentrations.
n.t., not tested.
Isolation and Characterization of
Persister Cells From MRSA Biofilm After
Treatment With High Concentrations of
Vancomycin
The potential selection of persister cells in S. aureus biofilm due
to the treatment with high bactericidal antibiotic concentrations
(vancomycin) was also investigated. To do so, two different
experiments using IMC were performed (Figure 5). As bacterial
cells in a persister status are less metabolically active, they do
not produce detectable heat (Grassi et al., 2017), but the heat
can be measured again when cells revert to a normal-growing
phenotype. First, the heat produced by 24 h-old biofilms of
MRSA incubated with vancomycin was monitored in real time
in the calorimeter (Figure 5A). After 24 h measurement beads
were collected (washed to remove the antibiotic) and analyzed
one more time by IMC for 48 h after inoculation in fresh
medium (Figure 5B).
As observed during the IMC analysis of the MRSA biofilm
treated with vancomycin (Figure 5A), all the drug concentrations
(ranging from 256 to 1024 µg/ml) used determined a suppression
of any detectable thermogenic process.
By contrast, the same samples after the vancomycin treatment
and re-inoculation in fresh medium, produced heat (≈50 µW
maximum peak), suggesting that some bacteria were still present
on the beads after the 24 h-incubation (Figure 5B). However,
a lower heat production and a delay in the time of the heat
detection were observed in comparison to the heat produced by
the positive control (without drug pre-treatment), suggesting that
a less active metabolic status might characterize the biofilm cells
after the treatment with vancomycin (Figure 5B).
In order to evaluate the presence of cells in a persister
status and exclude the selection of naturally occurring
vancomycin-resistant mutants, MRSA biofilm cells treated
with 1024 µg/ml drug were dislodged from glass beads
and challenged with 100xMIC vancomycin (100 µg/ml) in
PBS/1%CAMHB (Figure 6A). Suspensions were plated on solid
medium at different time points. As depicted in Figure 6A,
free-floating cells dislodged from treated biofilms and re-
incubated with 100xMIC vancomycin (P+VAN100xMIC) seemed
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FIGURE 5 | Isothermal microcalorimetry evaluation of anti-biofilm activity of vancomycin against biofilm MRSA in real-time (A) during and (B) after 24 h-treatment.
Numbers represent antibiotic concentrations (µg/ml). A negative control has been used to confirm medium sterility (NC). Representative data of replicated
experiments are reported.
not to be affected by the high drug concentrations, as indicated
by the CFUs number observed during 6 h-incubation. No
difference in the CFUs number was observed for the same
sample of bacteria derived from pre-treated biofilms (P),
which were not challenged with 100xMIC vancomycin, in
comparison to the value obtained for P+VAN100xMIC sample.
By contrast, cells derived from biofilm without any drug
pre-treatment (GC) showed an increase of 1.5 log10 CFU/ml
in comparison to the initial inoculum after 6 h-incubation in
PBS+1%CAMHB. The same samples exposed to 100xMIC
vancomycin (GC+VAN100xMIC) showed a reduction of ∼ 2.5
log10 CFU/ml after 6 h in comparison to the untreated GC
(7.2 ± 2.1 × 103 vs. 2.4 ± 3.9 × 106 CFUs/ml respectively),
indicating a higher susceptibility to 100xMIC vancomycin than
that observed P+VAN100xMIC sample.
In order to confirm the bactericidal activity of vancomycin
used in the experiment, the antibiotic was tested against
free-floating bacteria (dislodged from untreated biofilm) in fresh
medium (Figure 6B). Cells incubated in broth reached an early
exponential growth within 6 h (from 5.5 ± 3.2 × 104 to
8.2 ± 4.6 × 107 CFUs/ml), whereas, when exposed to 100xMIC
vancomycin, a complete killing of free-floating bacteria was
observed after 6 h-incubation.
To further confirm our hypothesis that the anti-biofilm
treatment with vancomycin induced persistence in MRSA
biofilm, treated biofilm cells were re-incubated in rich growth
medium after sonication to evaluate by IMC the characteristic
delay in heat production (lag phase λ) in comparison to an
untreated control, due to the reversion to a normal growing
phenotype already observed by Grassi et al. (2017). As depicted
in Figure 7A, both GC and P samples produced heat in
fresh medium (with a trend similar to the curves depicted in
Figure 5B). However, a clear temporal shift was observed in heat
flow curves produced by P compared to untreated GC. Indeed,
a 1λ = 3.2 h was calculated between the first peaks of GC
(λ = 3.8 h) and P (λ = 7 h) (Figure 7B), suggesting that the cells
of sample P remained in a metabolically inactive status and, after
6 h (the time needed for the treated samplet’s heat flow to exceed
the detection limit of ∼104–105 CFUs/ml (Butini et al., 2018b)
incubation in fresh CAMHB), they reverted into metabolically
active cells (Supplemetary Figure S6).
Bactericidal Effect of Vancomycin and
Daptomycin Staggered Administration
Against MRSA Biofilm
Based on the assumption that vancomycin efficiently kills the
susceptible portion of the staphylococcal biofilm community,
thus selecting for persistent cells, a possible synergistic
eradicating activity of a sequential administration of bactericidal
concentration of vancomycin (1024 µg/ml) and sub-eradicating
concentration of daptomycin (16 µg/ml) was evaluated. As
depicted in Figure 8, the bacterial load of a 24 h-old biofilm
firstly treated with 1024 µg/ml vancomycin and then receiving
no daptomycin was reduced by ∼2 log10. Similarly, a first
24 h-incubation without vancomycin treatment and a following
exposition to 16 µg/ml daptomycin resulted in a ∼2 log10.
Interestingly, when sequentially combined, a 24 h-treatment
with vancomycin, followed by 24 h-incubation with daptomycin,
showed a complete killing of biofilm viable cells, highlighting
a synergistic eradicating activity against MRSA biofilm mostly
populated by persister cells.
DISCUSSION
The determination of antimicrobial susceptibilities is of
fundamental importance during the developmental procedure
of new antimicrobial drugs’ discovery, as well as in predicting
possible therapeutic outcomes during the pharmacological
management of an infection. As around 80% of human
infections are due to sessile bacteria, the development of
biofilm-specific antimicrobial assays is needed (Percival et al.,
2015; Ciofu et al., 2017).
Isothermal microcalorimetry is a highly sensitive technique
that enables a real-time monitoring of bacterial viability in terms
of metabolism-related heat production (Braissant et al., 2010).
This method was widely used and validated in our laboratory
for testing the anti-biofilm activity of different antimicrobial
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FIGURE 6 | Characterization of persister cells isolated from MRSA biofilm after 24 h-treatment with 1024 µg/ml vancomycin. The exposure to high bactericidal
concentrations of vancomycin (100x MICVAN = 100 µg/ml) was evaluated by colony counting (Log10CFUs/mL) of MRSA persister cells during 6 h-incubation in
(A) PBS/1% CAMHB and (B) CAMHB. GC, growth control; GC+V100xMIC, growth control exposed to 100xMIC vancomycin; P, persister cells; P+V100xMIC persister
cells exposed to 100xMIC vancomycin. Data are expressed as mean ± SD, 3 ≤ n ≤ 6.
formulations, including antibiotics (Oliva et al., 2014; Butini et al.,
2018a,b; Casadidio et al., 2018), antifungals (Furustrand Tafin
et al., 2013), and bacteriophages (Tkhilaishvili et al., 2018a,b).
Here, the analysis of the activity of commonly prescribed
antibiotics against two laboratory strains of S. aureus performed
by IMC showed that both planktonic MSSA and MRSA
were susceptible to all the tested antibiotics tested (EUCAST,
2017), but considerable higher concentrations; 128xMHIC
and ≥ 8000xMHIC for daptomycin and rifampicin, respectively,
were needed to eradicate the biofilm of the same reference
strains. Moreover, it was not possible to determine the MBEC
for the other antibiotics tested, as live bacterial cells were
still attached to glass beads after treatment with the highest
tested antibiotic concentrations. The tolerance of S. aureus
biofilms (including those formed by clinical isolates) to high
concentrations of different antibiotics was already observed
in vitro (Singh et al., 2017; Di Luca et al., 2018) and in vivo (Patel
et al., 2000) and it might be responsible for the failure of the
monotherapy in the treatment of biofilm-associated infections
(Jacqueline and Caillon, 2014).
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FIGURE 7 | Characterization of persister cells isolated from MRSA biofilm after 24 h-treatment with 1024 µg/ml vancomycin. Revival assay in CAMHB by IMC
monitoring (A) the heat flow (µW) plotted against time (h) and (B) the total heat (J) produced during the experimental time (h). GC, growth control; P, persister cells;
NC, negative control. Representative data of replicated experiment are reported.
FIGURE 8 | Evaluation of the eradicating activity of the sequential treatment
vancomycin/daptomycin against a 24 h-old MRSA biofilm by sonication and
colony counting (Log10CFUs/mL). Numbers indicate vancomycin (V) and
daptomycin (D) concentrations (µg/ml). GC 72h; growth control of untreated
72 h-old biofilm. Data are expressed as mean ± SD, n = 3.
In the past, the presence of the extracellular matrix has
been proposed as responsible for the reduced permeability
of the biofilm to antibiotics (Mathur et al., 2005). However,
recent in vitro studies have showed that most antibiotics can
penetrate biofilm quite efficiently (Stewart et al., 2009; Singh
et al., 2010). Therefore, the presence of a subpopulation of
cells (within the sessile community) extremely tolerant to
conventional antibiotics could explain the difficulty in eradicating
biofilms and the relapse of the infection after the antibiotic
treatment (Conlon, 2014).
Interestingly, the microcalorimetric heat flow curves showed
a delay in the heat detection and a different curve shape in
comparison to the untreated biofilm control. Also the analysis
of λ and µ indicated that, as compared to the untreated
growth control, biofilm bacteria pre-treated with 1024 µg/ml
vancomycin exhibited a much longer lag phase and a slower
growth rate. This prolongation in lag time might be due to
a lower number of bacteria on the beads given by the partial
killing of the initial inoculum (Astasov-Frauenhoffer et al.,
2014) after the antibiotic treatment, which also induced a clear
decrease in bacterial metabolic activity, in comparison to the
number and the metabolic status of the untreated control cells.
These are recognized as characteristic features of persister cells
isolated after antibiotic treatment. Moreover, specifically in case
of vancomycin treatment, there is similarity between the growth
rate/concentration curve (J/h/µg/ml) reported in Figure 4 and
the persisters typical biphasic kill curve (bacterial inoculum/time,
Log CFUs/ml/h) (Fisher et al., 2017).
To confirm whether the heat produced by the pre-treated
biofilms (recorded by IMC) correlated with the presence of
persister cells selected by the killing of normal-growing cells
with the highest antibiotic concentrations, we focused our
research on the effect of vancomycin versus an in vitro 24 h-old
biofilm of MRSA.
When the effect of high concentrations of glycopeptide
(ranging from 128 to 1024 µg/ml) was tested against
the staphylococcal biofilm and monitored in real-time
(co-incubation of vancomycin with biofilm in the
microcalorimetric glass ampoules), no metabolism-related
heat flow was detected (Figure 5A). By contrast, when the
pre-treated biofilm samples were washed and re-incubated
in a fresh medium without any antibiotic, the presence of
a residual inoculum (∼5% as compared to the untreated
biofilm population) on the beads produced a detectable
amount of heat, which was observed for all the tested samples.
Since this effect was similar to the reversion pattern to a
normal-growing phenotype that was recently described by
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Grassi et al. (2017), it was reasoned that the bacterial cells
selected after biofilm treatment with 1024 µg/ml vancomycin
might be considered persister ones. The high tolerance of
free-floating cells dislodged from MRSA biofilm pre-treated
with vancomycin and subsequently challenged with 100xMIC
of the same glycopeptide in PBS/1%CAMHB confirmed this
hypothesis. Biofilm dislodged cells pre-treated with 1024 µg/ml
vancomycin were not able to replicate (within 6 h) when
maintained in a low-nutrient conditions and, once challenged
with extremely high doses of vancomycin, the CFUs number
remained rather constant over the time without any reduction.
Therefore, these biofilm-dislodged cells might be considered
persister. Nevertheless, when persisters were inoculated in fresh
rich medium and analyzed once more by IMC, they re-activated
their metabolic activities producing a detectable heat and, if
then challenged with 100xMIC vancomycin, they could be killed,
indicating a complete reversion to a normal-growing phenotype.
In addition, these data also excluded the presence of vancomycin
resistant clones.
We demonstrate that a deeper analysis of IMC curves
allows to detect and recognize in real-time the presence
of persister cells in a biofilm after receiving an anti-
biofilm treatment, thus making this technique also suitable
for the analysis and characterization of new anti-persisters
molecules. Moreover, it was shown that the scarce efficacy of
vancomycin administered alone against a 24 h-old S. aureus
biofilm in vitro is mainly due to the presence/selection
of persister cells, rather than resistance development or
inadequate antibiotic penetration (Conlon, 2014). This
might then explain the higher rate of failure of the
treatment based only on the use of this glycopeptide in the
clinical practice, if rifampin is not added in combination
(Niska et al., 2013).
Interestingly, the tolerance of S. aureus to 100xMIC
daptomycin has been also described in stationary phase cell
population (Lechner et al., 2012). However, here we report
that a sub-eradicating concentration of daptomycin (16 µg/ml),
which determined a reduction of barely 2 log10 when tested
alone against MRSA biofilm, was able to kill persisters cells
remaining within the biofilm on the beads after vancomycin
treatment. This observation suggests that the tolerance developed
to vancomycin cannot be considered multi-drug like in the
case of persisters raised during the inhibition of the translation
(Keren et al., 2004).
Since vancomycin clearly killed susceptible cells and selected
for non-growing dormant ones, we propose a sequential
administration of a combined vancomycin/daptomycin
treatment to achieve the killing of all viable biofilm cells.
The present results support the use of daptomycin in the
clinical practice against MRSA infection in case of failure with
vancomycin therapy.
CONCLUSION
We showed the selection/isolation of S. aureus persister
cells from a 24 h-old biofilm after treatment with high
concentrations of vancomycin. Moreover, IMC detecting in real-
time the presence of these slowly-growing cells, which resuscitate
upon treatment discontinuation, might prove to be a useful
technique for the development and the investigation of anti-
persister drugs.
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